Inception Return
(10/5/2009)
|
10.96 %
|
|
YTD Return
|
-4.52 %
|
|
NAVPS
(12/11/2024)
|
$49.46
|
|
Change
|
($0.08) / -0.16 %
|
|
|
Growth of $10,000
(As of November 30, 2024)
|
|
MER
|
2.31 %
|
|
Assets ($mil)
|
$19.10
|
|
Rank (1Yr)
|
112/114
|
|
Std Dev (3Yr)
|
14.54 %
|
|
Volatility Ranking (3Yr)
|
7/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Back Fee Only
|
|
Max Front End
|
3.00 %
|
|
Max Back End
|
-
|
|
Sales Status
|
Capped
|
|
|
Objective
The Fund seeks to provide above average long-term returns by investing in securities of global, small-cap companies. The Fund is primarily invested in equity securities of companies located around the world. The amount invested in any one country varies depending upon the economic, investment, and market outlook and opportunities in each area. The Fund may also invest in treasury bills or short-term investments, not exceeding three years to maturity, from time to time.
|
Fund Manager
Manulife Investment Management Limited
Portfolio Manager
Manulife Asset Management Limited
Sub-Advisor
Paul Moroz, Mawer Investment Management Ltd.
Christian Deckart, Mawer Investment Management Ltd.
|
|
Asset Allocation
(As of October 31, 2024)
|
Sector Allocation
(As of October 31, 2024)
|
Geographic Allocation
(As of October 31, 2024)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| De' Longhi SpA | International Equity | Consumer Goods | European Union | 5.36% |
| Hikma Pharmaceuticals PLC | International Equity | Healthcare | European Union | 5.02% |
| Ipsos SA | International Equity | Consumer Services | European Union | 4.78% |
| Alten SA | International Equity | Technology | European Union | 4.62% |
| Fagron NV | International Equity | Healthcare | European Union | 4.07% |
| Donnelley Financial Solutions Inc | US Equity | Industrial Services | United States | 3.99% |
| Gps Participacoes e Empreendimentos SA | International Equity | Industrial Services | Latin America | 3.98% |
| Softcat PLC | International Equity | Technology | European Union | 3.54% |
| Orkla ASA | International Equity | Consumer Goods | Other European | 3.52% |
| Dermapharm Holding SE | International Equity | Healthcare | European Union | 3.40% |
Performance Data
(As of November 30, 2024)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
0.94
|
-5.86
|
-7.39
|
-4.52
|
-0.82
|
-3.55
|
1.51
|
7.22
|
|
Benchmark
|
6.51
|
10.72
|
14.05
|
22.42
|
29.26
|
7.86
|
9.67
|
9.78
|
|
Quartile Ranking
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
2
|
|
Calendar Return (%)
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
|
Fund
|
13.47
|
-18.56
|
4.27
|
14.52
|
24.39
|
-3.44
|
21.09
|
-1.13
|
31.04
|
11.29
|
|
Benchmark
|
14.59
|
-13.14
|
15.50
|
11.07
|
20.09
|
-7.34
|
15.40
|
7.47
|
16.61
|
9.59
|
|
Quartile Ranking
|
2
|
4
|
4
|
3
|
1
|
2
|
1
|
2
|
1
|
4
|